Literature DB >> 9323358

Molecular analysis of the ribosomal L11 protein gene (rplK = relC) of Streptomyces griseus and identification of a deletion allele.

S Kawamoto1, D Zhang, K Ochi.   

Abstract

The rplK (= relC) gene, which codes for ribosomal protein L11, was cloned from Streptomyces griseus IFO13189 using a screening procedure based on polymerase chain reaction amplification of a gene segment that subsequently allowed the isolation of the complete gene from a gene library. rplK lies between the nusG gene, encoding a protein involved in antitermination of transcription, and the rplA gene, which encodes the ribosomal protein L1. Comparison of the rplK gene sequences of the wild-type strain and the presumed relC mutant strain 3-3 (originally isolated as a thiopeptin-resistant isolate) revealed a 12-bp deletion within the rplK gene from the mutant, flanked by a 4-bp repeat sequence in the corresponding region in the wild type. When the wild-type rplK gene was propagated on a low-copy-number vector in the relC mutant 3-3, the ability to produce guanosine 5'-diphosphate 3'-diphosphate, streptomycin, and submerged spores was completely restored to parental levels. The impaired ability to form aerial mycelium was, however, unaffected. Western blotting analysis showed that the ribosomes from the relC mutant 3-3 incorporate the mutant L11 protein normally, although the level of incorporation is approximately one-third that of the wild-type L11 protein in ribosomes of the parent strain. Propagation of the mutant rplK gene in the wild-type strain resulted in marked defects in growth, streptomycin production, and aerial mycelium formation, indicating that the mutant L11 protein exerts certain negative effects in the cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9323358     DOI: 10.1007/s004380050528

Source DB:  PubMed          Journal:  Mol Gen Genet        ISSN: 0026-8925


  8 in total

1.  Novel approach for improving the productivity of antibiotic-producing strains by inducing combined resistant mutations.

Authors:  H Hu; K Ochi
Journal:  Appl Environ Microbiol       Date:  2001-04       Impact factor: 4.792

2.  EshA accentuates ppGpp accumulation and is conditionally required for antibiotic production in Streptomyces coelicolor A3(2).

Authors:  Natsumi Saito; Jun Xu; Takeshi Hosaka; Susumu Okamoto; Hiroyuki Aoki; Mervyn J Bibb; Kozo Ochi
Journal:  J Bacteriol       Date:  2006-07       Impact factor: 3.490

3.  Activation of dormant bacterial genes by Nonomuraea sp. strain ATCC 39727 mutant-type RNA polymerase.

Authors:  Adelfia Talà; Guojun Wang; Martina Zemanova; Susumu Okamoto; Kozo Ochi; Pietro Alifano
Journal:  J Bacteriol       Date:  2008-12-01       Impact factor: 3.490

4.  Physiological analysis of the stringent response elicited in an extreme thermophilic bacterium, Thermus thermophilus.

Authors:  Koji Kasai; Tomoyasu Nishizawa; Kosaku Takahashi; Takeshi Hosaka; Hiroyuki Aoki; Kozo Ochi
Journal:  J Bacteriol       Date:  2006-10       Impact factor: 3.490

5.  Molecular and functional analyses of the gene (eshA) encoding the 52-kilodalton protein of Streptomyces coelicolor A3(2) required for antibiotic production.

Authors:  S Kawamoto; M Watanabe; N Saito; A Hesketh; K Vachalova; K Matsubara; K Ochi
Journal:  J Bacteriol       Date:  2001-10       Impact factor: 3.490

6.  The relA/spoT-homologous gene in Streptomyces coelicolor encodes both ribosome-dependent (p)ppGpp-synthesizing and -degrading activities.

Authors:  O H Martínez-Costa; M A Fernández-Moreno; F Malpartida
Journal:  J Bacteriol       Date:  1998-08       Impact factor: 3.490

7.  Activation of antibiotic biosynthesis by specified mutations in the rpoB gene (encoding the RNA polymerase beta subunit) of Streptomyces lividans.

Authors:  Haifeng Hu; Qin Zhang; Kozo Ochi
Journal:  J Bacteriol       Date:  2002-07       Impact factor: 3.490

8.  Catalytic and non-catalytic roles for the mono-ADP-ribosyltransferase Arr in the mycobacterial DNA damage response.

Authors:  Christina L Stallings; Linda Chu; Lucy X Li; Michael S Glickman
Journal:  PLoS One       Date:  2011-07-18       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.